These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 36077466)

  • 1. Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy.
    Chaudhuri A; Kumar DN; Shaik RA; Eid BG; Abdel-Naim AB; Md S; Ahmad A; Agrawal AK
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth of Metastatic Triple-Negative Breast Cancer Is Inhibited by Deep Tumor-Penetrating and Slow Tumor-Clearing Chemotherapy: The Case of Tumor-Adhering Liposomes with Interstitial Drug Release.
    Stras S; Howe A; Prasad A; Salerno D; Bhatavdekar O; Sofou S
    Mol Pharm; 2020 Jan; 17(1):118-131. PubMed ID: 31825626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances of Nanotechnology in the Diagnosis and Therapy of Triple- Negative Breast Cancer (TNBC).
    Kanugo A; Gautam RK; Kamal MA
    Curr Pharm Biotechnol; 2022; 23(13):1581-1595. PubMed ID: 34967294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances.
    Miller-Kleinhenz JM; Bozeman EN; Yang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(6):797-816. PubMed ID: 25966677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
    Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W
    Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy.
    Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A
    Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive review on lipid nanocarrier systems for cancer treatment: fabrication, future prospects and clinical trials.
    Kabil MF; Badary OA; Bier F; Mousa SA; El-Sherbiny IM
    J Liposome Res; 2024 Mar; 34(1):135-177. PubMed ID: 37144339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer.
    Jain V; Kumar H; Anod HV; Chand P; Gupta NV; Dey S; Kesharwani SS
    J Control Release; 2020 Oct; 326():628-647. PubMed ID: 32653502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
    Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-based nanocarriers for breast cancer treatment - comprehensive review.
    Talluri SV; Kuppusamy G; Karri VV; Tummala S; Madhunapantula SV
    Drug Deliv; 2016 May; 23(4):1291-305. PubMed ID: 26430913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Advances in Triple Negative Breast Cancer Treatment: Focus on Poly (L-lactide-coglycolide) Nanoparticles.
    Towner RA; Dissanayake R; Ahmed M
    J Pharmacol Exp Ther; 2024 Jun; 390(1):53-64. PubMed ID: 38580448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Drug Therapy to Overcome Chemoresistance in Triple-negative Breast Cancer.
    Kumari M; Krishnamurthy PT; Sola P
    Curr Cancer Drug Targets; 2020; 20(8):559-572. PubMed ID: 32370716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid Lipid Nanoparticles, an Alternative for the Treatment of Triple-Negative Breast Cancer.
    Llaguno-Munive M; Vazquez-Lopez MI; Garcia-Lopez P
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanosoldiers: A promising strategy to combat triple negative breast cancer.
    Pawar A; Prabhu P
    Biomed Pharmacother; 2019 Feb; 110():319-341. PubMed ID: 30529766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy.
    He X; Cai K; Zhang Y; Lu Y; Guo Q; Zhang Y; Liu L; Ruan C; Chen Q; Chen X; Li C; Sun T; Cheng J; Jiang C
    ACS Appl Mater Interfaces; 2018 Nov; 10(46):39455-39467. PubMed ID: 30362704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promises of Lipid-based Drug Delivery Systems in the Management of Breast Cancer.
    Thotakura N; Gupta MM; Rajawat JS; Raza K
    Curr Pharm Des; 2021; 27(45):4568-4577. PubMed ID: 34323182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer.
    Guney Eskiler G; Cecener G; Egeli U; Tunca B
    Pharm Res; 2018 Sep; 35(11):218. PubMed ID: 30255456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles.
    Alavi M; Hamidi M
    Drug Metab Pers Ther; 2019 Feb; 34(1):. PubMed ID: 30707682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment.
    Graván P; Aguilera-Garrido A; Marchal JA; Navarro-Marchal SA; Galisteo-González F
    Adv Colloid Interface Sci; 2023 Apr; 314():102871. PubMed ID: 36958181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.